Physician

Mark Callow, MD

According to 2025 Medicare claims, Mark Callow, MD (NPI: 1457644338) practices epileptologists in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (NPI: 1801840434; TIN: 311405915) and primary practice location at 45219-2316.

Callow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 296 traditional Medicare patients, billed 679 HCPCS/CPT codes, and received $38,978 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 4,685 prescription claims across 470 beneficiaries totaling $2,780,600 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). 2023 DME data shows 11 claims. Open Payments data shows 32 records totaling $3,934. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $23,893 and ending at $38,978. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $44,545 to $2,780,600. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	211	286	$23,893
2017	429	766	$65,388
2018	347	630	$43,682
2019	407	781	$68,826
2020	320	547	$40,628
2021	284	538	$44,978
2022	302	540	$42,866
2023	271	495	$36,978
2024	296	679	$38,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	181	$44,545
2016	174	743	$314,391
2017	330	3,875	$1,310,522
2018	333	4,177	$1,407,150
2019	350	4,361	$1,429,046
2020	344	3,968	$1,458,726
2021	432	4,340	$2,269,894
2022	456	5,077	$2,655,066
2023	429	5,000	$2,638,342
2024	470	4,685	$2,780,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$278
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	59	91	$149
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	87	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	110	134	$42
95816	Measurement of brain wave activity (eeg), awake and drowsy	59	59	$37
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	111	148	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	128	3,581	$740,660
Briviact	Brivaracetam	180	5,216	$332,963
Fintepla	Fenfluramine Hcl	14	420	$188,212
Xcopri	Cenobamate	148	4,572	$177,337
Aptiom	Eslicarbazepine Acetate	62	1,862	$140,288

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$3,934	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Callow, MD?

Tedicare shows public-source Medicare data for Mark Callow, MD (NPI 1457644338), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Callow, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Callow, MD?

Mark Callow, MD is linked to UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY, LLC (billing NPI 1801840434) in the available physician profile data.

Does Mark Callow, MD have Open Payments data?

Mark Callow, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.